CoChat

CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer

Open access
Tsujino, Takuya, Takai, Tomoaki, Hinohara, Kunihiko, Gui, Fu, Tsutsumi, Takeshi, Bai, Xiao, Miao, Chenkui, Feng, Chao, Gui, Bin, Sztupinszki, Zsofia, Simoneau, Antoine, Xie, Ning, Fazli, Ladan, Dong, Xuesen, Azuma, Haruhito, Choudhury, Atish D., Mouw, Kent W., Szallasi, Zoltan, Zou, Lee, Kibel, Adam S., Jia, Li · 2023 · Nature Communications
Cited by 126

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Prostate cancer harboring BRCA1/2 mutations are often exceptionally sensitive to PARP inhibitors. However, genomic alterations in other DNA damage response genes have not been consistently predictive of clinical response to PARP inhibition. Here, we perform genome-wide CRISPR-Cas9 knockout screens in BRCA1/2-proficient prostate cancer cells and identify previously unknown genes whose loss has a profound impact on PARP inhibitor response. Specifically, MMS22L deletion, frequently observed (up to 14%) in prostate cancer, renders cells hypersensitive to PARP inhibitors by disrupting RAD51 loading required for homologous recombination repair, although this response is TP53-dependent. Unexpectedly, loss of CHEK2 confers resistance rather than sensitivity to PARP inhibition through increased expression of BRCA2, a target of CHEK2-TP53-E2F7-mediated transcriptional repression. Combined PARP and ATR inhibition overcomes PARP inhibitor resistance caused by CHEK2 loss. Our findings may inform the use of PARP inhibitors beyond BRCA1/2-deficient tumors and support reevaluation of current biomarkers for PARP inhibition in prostate cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-023-35880-y

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 126

Metadata

Authors
Tsujino, T., Takai, T., Hinohara, K., Gui, F., Tsutsumi, T., Bai, X., Miao, C., Feng, C., Gui, B., Sztupinszki, Z., Simoneau, A., Xie, N., Fazli, L., Dong, X., Azuma, H., Choudhury, A. D., Mouw, K. W., Szallasi, Z., Zou, L., Kibel, A. S., & Jia, L.
Venue
Nature Communications
Published
2023-01-17
Volume
14
Issue
1
Pages
252-252
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4316804884
Cited by
126
References
27
FWCI
13.04
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. https://app.cochat.ai/papers/10.1038/s41467-023-35880-y
The paper
Tsujino, T., Takai, T., Hinohara, K., Gui, F., Tsutsumi, T., Bai, X., Miao, C., Feng, C., Gui, B., Sztupinszki, Z., Simoneau, A., Xie, N., Fazli, L., Dong, X., Azuma, H., Choudhury, A. D., Mouw, K. W., Szallasi, Z., Zou, L., . . . Jia, L. (2023). CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature Communications. https://doi.org/10.1038/s41467-023-35880-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.